Identification of Potential or Preclinical Cognitive Impairment and the Implications of Sophisticated Screening with Biomarkers and Cognitive Testing: Does It Really Matter?
The last decade has seen an enormous growth in the interest in the recognition of and intervention in those diagnosed and living with the whole range of cognitive impairment and frank dementia. In the western world, the recognition of the impact on patients, families, health care systems, and societ...
Main Author: | Michael Gordon |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2013/976130 |
Similar Items
-
Cognitive and neuroimaging markers for preclinical vascular cognitive impairment
by: Ellen Lowry, et al.
Published: (2021-01-01) -
Rethinking the link between cognitive sophistication and politically motivated reasoning.
by: Tappin, Ben M, et al.
Published: (2022) -
Does size really matter?
by: David G Heckel
Published: (2020-12-01) -
Coopetition: does it really matter?
by: Natália Rohenkohl do Canto, et al.
Published: (2017-12-01) -
Dosimetry: Does it Really Matter?
by: David Chee.Eng Ng
Published: (2013-01-01)